Nanoligent (private company)

See something wrong or missing? Let us know
Offices:Barcelona
Business model:B2B

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 16.99M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nanoligent

Name Criteria
Germany Atai Life Sciences
77%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Flow Neuroscience
77%
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Poland Jutro Medical
77%
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
77%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Baseimmune
77%
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
77%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Insempra
77%
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Xenothera
77%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany Formo
77%
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
77%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top